Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.
D000284:Administration, Oral; D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D002794:Choline / Q000378:metabolism; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D000077204:Temozolomide; D016896:Treatment Outcome; D014867:Water / Q000032:analysis
D018906:Antineoplastic Agents, Alkylating; D014867:Water; D003606:Dacarbazine; D002794:Choline; D000077204:Temozolomide